Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02697591
Title An Open-Label, Dose-Escalation, Safety Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation
Indications

lung non-small cell carcinoma

renal cell carcinoma

Advanced Solid Tumor

melanoma

endometrial adenocarcinoma

Therapies

INCAGN01876

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
Yale University New Haven Connecticut 06511 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering at Monmouth Middletown New Jersey 07748 United States Details
MSK Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field